Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 9,557,000 | 9,179,000 | 8,149,000 | 9,086,000 | 8,503,000 |
| Cost of Goods | 3,082,000 | 3,011,000 | 2,968,000 | 3,112,000 | 3,310,000 |
| Gross Profit | 6,475,000 | 6,168,000 | 5,181,000 | 5,974,000 | 5,193,000 |
| Operating Expenses | 3,949,000 | 3,512,000 | 4,003,000 | 3,663,000 | 3,146,000 |
| Operating Income | 2,526,000 | 2,656,000 | 1,178,000 | 2,311,000 | 2,047,000 |
| Interest Expense | 685,000 | 694,000 | 723,000 | 747,000 | 776,000 |
| Other Income | 2,080,000 | -394,000 | 1,518,000 | -782,000 | 1,830,000 |
| Pre-tax Income | 3,921,000 | 1,568,000 | 1,973,000 | 782,000 | 3,101,000 |
| Income Tax | 705,000 | 136,000 | 243,000 | 155,000 | 271,000 |
| Net Income Continuous | 3,216,000 | 1,432,000 | 1,730,000 | 627,000 | 2,830,000 |
| Net Income | $3,216,000 | $1,432,000 | $1,730,000 | $627,000 | $2,830,000 |
| EPS Basic Total Ops | 5.98 | 2.66 | 3.22 | 1.17 | 5.27 |
| EPS Basic Continuous Ops | 5.98 | 2.66 | 3.22 | 1.17 | 5.27 |
| EPS Diluted Total Ops | 5.93 | 2.65 | 3.20 | 1.17 | 5.22 |
| EPS Diluted Continuous Ops | 5.93 | 2.65 | 3.20 | 1.17 | 5.22 |
| EPS Diluted Before Non-Recurring Items | 5.64 | 6.02 | 4.90 | 5.31 | 5.58 |
| EBITDA(a) | $4,233,000 | $3,997,000 | $3,365,000 | $3,579,000 | $3,504,000 |